Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other

ALTERITY THERAPEUTICS LTD (PRAN) Create: Alert

All | News | Filings
Date FiledTypeDescription
10/02/2023 F-3 Form F-3 - Registration statement by foreign private issuers:
08/23/2023 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "REPORT OF FOREIGN PRIVATE ISSUER",
"Alterity Granted New Composition of Matter Patent in Europe"
08/22/2023 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "REPORT OF FOREIGN PRIVATE ISSUER",
"ATH to present New Biomarker data at International Congress"
08/15/2023 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "REPORT OF FOREIGN PRIVATE ISSUER",
"Alterity receives a $4.74 million R&D Tax Refund"
07/31/2023 6-K Quarterly results
07/26/2023 6-K Quarterly results
04/27/2023 6-K Quarterly results
04/26/2023 6-K Quarterly results
04/04/2023 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "REPORT OF FOREIGN PRIVATE ISSUER",
"First Patient Enrolled in UK in Phase II Clinical Trial"
03/16/2023 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "REPORT OF FOREIGN PRIVATE ISSUER",
"Application for quotation of securities - ATH"
03/16/2023 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "REPORT OF FOREIGN PRIVATE ISSUER",
"Notice Under Section 708A"
03/15/2023 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "REPORT OF FOREIGN PRIVATE ISSUER",
"Proposed issue of securities - ATH"
03/14/2023 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "REPORT OF FOREIGN PRIVATE ISSUER",
"US patent grant and license agreement"
03/09/2023 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "REPORT OF FOREIGN PRIVATE ISSUER",
"Investor Webinar Presentation"
02/28/2023 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "REPORT OF FOREIGN PRIVATE ISSUER",
"Half Yearly Report and Accounts"
02/02/2023 6-K Quarterly results
01/31/2023 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "REPORT OF FOREIGN PRIVATE ISSUER",
"Appendix 4C and Quarterly Cash Flow Report"
01/30/2023 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "REPORT OF FOREIGN PRIVATE ISSUER",
"ATH434 Prevents Brain Cell loss in Parkinsons Animal Model"
01/25/2023 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "REPORT OF FOREIGN PRIVATE ISSUER",
"ATH434 Clinical Trial Launched in Italy"
01/09/2023 6-K Quarterly results
01/06/2023 6-K Quarterly results
01/03/2023 6-K Quarterly results
12/29/2022 6-K Quarterly results
12/15/2022 6-K Quarterly results
12/15/2022 6-K Quarterly results
11/16/2022 6-K Quarterly results
11/14/2022 6-K Quarterly results
11/14/2022 6-K Quarterly results
11/14/2022 6-K Quarterly results
11/07/2022 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "REPORT OF FOREIGN PRIVATE ISSUER",
"Presentation of bioMUSE urinary symptom profile data"
10/31/2022 SC 13D/A Life Biosciences LLC reports a 4.7% stake in Alterity Therapeutics Limited
10/28/2022 6-K Quarterly results
10/26/2022 6-K Quarterly results
10/13/2022 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "REPORT OF FOREIGN PRIVATE ISSUER",
"ATH434 Clinical Trial launched in Australia"
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy